Biocomposites-based on chitooligosaccharides for biomedical applications
- Authors
- Murugan, Sesha Subramanian; Kim, Se-Kwon; Dalavi, Pandurang Appana; Venkatesan, Jayachandran; Seong, Gi Hun
- Issue Date
- Feb-2022
- Publisher
- Springer International Publishing
- Keywords
- Biomedical; Chitooligosaccharides; Drug delivery; Tissue engineering
- Citation
- Chitooligosaccharides: Prevention and Control of Diseases, pp 173 - 183
- Pages
- 11
- Indexed
- SCOPUS
- Journal Title
- Chitooligosaccharides: Prevention and Control of Diseases
- Start Page
- 173
- End Page
- 183
- URI
- https://scholarworks.bwise.kr/erica/handle/2021.sw.erica/120559
- DOI
- 10.1007/978-3-030-92806-3_11
- Abstract
- Significant development has been achieved in searching the biocompatible biomaterials for various biological and biomedical applications. For example, Chitooligosacchairdes (COS), the derivative of chitosan, is a water-soluble natural cationic biopolymer that has been extensively used for biological, tissue engineering, and drug delivery applications. Antimicrobial and antitumor application of COS and their derivatives were presented in the present chapter. COS has been used in studying cardiac, nerve, and skin tissue engineering applications. Due to the cationic nature of COS, the utilization of gene and drug delivery are also discussed. In addition, COS can be modified and tuned concerning the applications. The biocompatible, biodegradable, and non-toxic nature of COS can be potentially explored for further biological and biomedical applications. © The Author(s), under exclusive license to Springer Nature Switzerland AG 2022. All rights reserved.
- Files in This Item
-
Go to Link
- Appears in
Collections - COLLEGE OF ENGINEERING SCIENCES > DEPARTMENT OF BIONANO ENGINEERING > 1. Journal Articles

Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.